Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?

Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) Vol. 136; no. 6; pp. 599 - 601
Main Authors: García-Granja, Pablo Elpidio, Sandín-Fuentes, María, García-Morán, Emilio, Sevilla, Teresa, Rubio, Jerónimo
Format: Journal Article
Language:English
Published: United States 08-08-2017
Subjects:
Action Potentials
Anti-Arrhythmia Agents - adverse effects
Atrioventricular Block - diagnosis
Atrioventricular Block - drug therapy
Atrioventricular Block - etiology
Atrioventricular Block - physiopathology
Cardiomyopathy, Hypertrophic - complications
Cardiomyopathy, Hypertrophic - diagnostic imaging
Cardiomyopathy, Hypertrophic - physiopathology
Electrocardiography
Heart Conduction System - drug effects
Heart Conduction System - physiopathology
Heart Rate - drug effects
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Predictive Value of Tests
Propafenone - adverse effects
propafenone
hypertrophic cardiomyopathy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.117.029572